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Stem cell population size is highly regulated across
species and tissue types, and alterations are associ-
ated with premature tissue failure or cancer. We
assessed whether the tumor suppressor and media-
tor of cell contact inhibition Nf2/merlin plays a role in
governing the hematopoietic stem cell pool by stem
cell-autonomous or niche-determined processes.
Hematopoietic stem cells in Nf2-deficient mice
were increased in number and demonstrated a
marked shift in location to the circulation. These
changes were entirely dependent on changes in the
microenvironment, with a marked increase in trabec-
ular bone and marrow vascularity associated with
increased VEGF, but without cell-autonomous alter-
ations in stem cell characteristics. Nf2/merlin is criti-
cal for maintaining normal structure and function of
the hematopoietic stem cell niche. It limits both
bone and vascular components, and our model sug-
gests that it thereby constrains stem cell number and
position.
INTRODUCTION
Stem cells reside in specialized microenvironments or ‘‘niches’’
that are essential for their maintenance and proper function
(Fuchs et al., 2004). Although components of hematopoietic
stem cell (HSC) niches in the bone marrow have been defined,
including osteoblasts, osteoclasts, and possibly perivascular
cells, questions remain about how heterologous cells contribute
to HSC regulation in terms of both localization and function (Calvi
et al., 2003; Kiel et al., 2005; Kollet et al., 2006; Zhang et al.,
2003). A key role for the niche is to protect and maintain the
stem cell pool by keeping the cells in a quiescent state and
thereby preventing their exhaustion. However, the mobility ofHSCs suggests that their interaction with the niche also is highly
dynamic with a substantial tendency to disengage. The microen-
vironmental architecture of the HSC niche is complex, with stem
cells, stromal cells, and vascular cells intermingled at the bone
surface. It is likely that physical interactions and cell:cell commu-
nication between these different cellular components play
important roles to keep the niche properly balanced and to main-
tain HSC homeostasis, but the bases for these interactions are
poorly defined.
The ubiquitously expressed tumor suppressor gene Neurofi-
bromatosis 2 (Nf2) encodes a protein, merlin, that plays a key
role in mediating cell:cell communication. Loss of merlin function
is associated with development of multiple cancers in both
humans and mice (McClatchey and Giovannini, 2005). Merlin is
localized to the inner surface of the plasma membrane connect-
ing membrane-bound proteins to the actin cytoskeleton and
thereby providing a link between external cues and the cell’s
inner machinery (McClatchey and Giovannini, 2005). It has
been shown that a characteristic of Nf2 deficiency in a range
of primary cell types is a lack of contact-mediated inhibition of
proliferation and an inability to form stable cadherin-mediated
cell:cell junctions (Lallemand et al., 2003). A mechanism was re-
cently demonstrated whereby merlin in osteoblasts coordinates
stabilization of adherens junctions upon cell:cell contact and in-
hibits signaling through the epidermal growth factor receptor
(EGFR) (Curto et al., 2007). Despite these profound effects in
multiple cell types in vitro and its association with tumor develop-
ment, little is known about the role of Nf2 in regulation of normal
tissue homeostasis in vivo. A recent study showed that Nf2 is
crucial for normal tissue morphogenesis during early embryonic
development by regulating cell-cell adhesion during tissue fusion
(McLaughlin et al., 2007).
Here we specifically addressed whether Nf2 plays a role in
the regulation of stem cells within the hematopoietic compart-
ment. We show that Nf2-deficient animals have dramatic HSC-
related phenotypes, affecting both localization (mobilization)
and number (increased pool size) of the stem cells. However,
these changes are not autonomous to the HSCs; rather, they
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Changes in the marrow include morphologic alterations with
increased trabecular bone and vascularity associated with
increased numbers of osteoblasts and VEGF, respectively.
Our findings therefore indicate that Nf2 plays a critical role in
the maintenance of normal architecture in the bone marrow mi-
croenvironment and in so doing may provide a non-cell-auton-
omous mechanism for modulating HSCs. Organization and
content of the niche appear to dominate key parameters of
stem cell homeostasis.
RESULTS
Inducible Deletion of Nf2 in the Mouse Hematopoietic
Compartment
Nf2 is known to be expressed in most tissues and cell types.
We examined the Nf2 mRNA levels in primitive subsets of hema-
topoietic cells and found robust expression in both the progeni-
tor (lin, c-kit+, Sca1) and more immature (lin, c-kit+, Sca1+)
populations (see Figure S1 available online). To further establish
a potential role for Nf2 in regulation of the hematopoietic com-
partment, we used genetically engineered mice bearing condi-
tional ‘‘floxed’’ alleles of the Nf2 gene (Giovannini et al., 2000).
We mated the floxed Nf2 mice with Mx1 Cre transgenic mice
to generate an inducible knockout mouse model (Kuhn et al.,
1995). Upon PolyIC administration, Mx1Cre is known to effi-
ciently induce gene deletion in all subsets of hematopoietic
stem and progenitor cells (HSC/Ps) as well as in the bone
marrow stroma (Larsson et al., 2003; Zhang et al., 2003). Accord-
ingly, when we analyzed our mice 12 weeks after polyIC treat-
ment, we found deletion of the Nf2 gene in 100% of hematopoi-
etic colony-forming cells (CFCs) and a nearly complete deletion
in adherent stroma cell layers derived from cultured bone mar-
row cells (Figure S2).
Both monoallelic and tissue specific biallelic Nf2 deletion in
mice has been shown to trigger the formation of spontaneous tu-
mors with age (Giovannini et al., 2000; McClatchey et al., 1998).
As expected, we observed the occurrence of sporadic tumors in
our mice from around 7 months after polyIC treatment, and few
animals survived beyond 8 months after knockout induction.
Further investigations describing the nature of the tumors in
these mice will be presented elsewhere. Here we focused our
attention to the analysis of the hematopoietic compartment prior
to malignant disease.
Marked Shift in Location to the Circulation and Increase
in HSC Number over Time after Nf2 Deletion
Four weeks following knockout induction, the Nf2-deficient mice
exhibited a substantial (two-fold) reduction in BM cellularity
compared to equally treated floxed littermate controls lacking
the Cre transgene (Figure 1A). This dramatic cell loss included
the subset enriched for hematopoietic stem/progenitor cells
(lin, c-kit+, Sca1+) (Figure 1B). Concurrently, we observed
a large increase in the numbers of HSC/Ps in the peripheral
blood as measured by colony-forming assays in vitro, pheno-
typic characterization by FACS, and competitive transplantation
assays in vivo (Figures 1C–1E). Thus, induced Nf2 deficiency re-
sults in a rapid and substantial egress of HSC/Ps from the BM
into the bloodstream. The levels of circulating primitive cells
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elevated 5 months after polyIC induction (Figure S3). This sus-
tained mobilization effect did not appear to exhaust hematopoi-
esis in the knockout animals, as they maintained intact levels of
all blood lineages (data not shown) and showed a restored BM
cellularity to normal levels after 5 months (Figure S3). On the
contrary, when the mice were analyzed 7 months after knockout
induction, we observed an increased cellularity in the BM cou-
pled with increased numbers of primitive LSK cells (Figures 1F
and 1G). Moreover, transplantation experiments at limit dilution
revealed a three-fold higher frequency of competitive repopulat-
ing units (CRU) in the knockout marrow (Figure 1H). Thus despite
a continuous outflow of primitive cells to the bloodstream, the
Nf2-deficient mice develop a moderate increase in total cell con-
tent of the marrow and a substantial increase in the size of the
stem cell pool. We concluded from these experiments that the
Nf2 knockout mice may exhibit two distinct phenotypes affecting
HSCs in biphasic manner: first one of mobilization and later one
of enhanced generation.
The HSC Changes Are Non-Cell-Autonomous
and Directly Associated with Changes
in the Bone Marrow Microenvironment
We next sought to determine the bases for the observed stem
cell phenotypes, first whether they were intrinsic to the stem cells
or due to alterations in the bone marrow microenvironment. To
address this for the mobilization phenotype, we created two
transplantation models by reconstituting either wild-type (WT)
mice with Nf2 floxed BM cells or, conversely, Nf2 floxed mice
with WT BM cells. When reconstituted after 8 weeks, these
mice were treated with polyIC to induce deletion of the floxed al-
leles. Interestingly,Nf2 knockout hematopoietic cells that had re-
constituted a WT stroma environment did not show egress into
the bloodstream. However, WT hematopoietic cells in an Nf2
knockout environment (4 weeks after polyIC induction) displayed
a mobilization phenotype similar to that originally observed in the
Nf2 knockout mice with a dramatic increase in CFC numbers in
the blood (Figures 2A and 2B). Thus, the mobilization phenotype
is specifically dependent on alterations in the bone marrow
microenvironment. We further asked whether the increased mo-
bilization could be coupled to defects in homing in Nf2-deficient
animals. Indeed, when wild-type hematopoietic cells were intra-
venously infused to Nf2-deficient hosts, they showed markedly
decreased homing to the marrow, while homing to the spleen
was normal (Figures 2C and 2D). Taken together, these experi-
ments show that Nf2 deficiency in the BM microenvironment
leads to both a retention defect, which increases mobilization,
and reduced homing of HSC/Ps in a non-cell-autonomous
manner.
Similarly, we determined the basis for the expansion of BM
cells and increased stem cell pool in aged Nf2 mutant mice. To
test whether this was due to an intrinsically mediated growth
advantage in the Nf2-deficient HSC, we transplanted wild-type
mice with Nf2 floxed BM and, following full reconstitution, in-
duced the gene deletion. Seven months after polyIC induction,
we analyzed the BM and measured the stem cell content in the
transplanted animals. Interestingly, we observed no significant
differences either in the total cell content of the BM or in the num-
bers of phenotypically defined HSCs, (Figures 2E and 2F). Thus
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Nf2/Merlin Regulates Stem Cell BehaviorFigure 1. Rapid Egress of HSCs and Progenitor Cells to the Circulation and Increase in HSC Number over Time following Nf2 Deletion
(A) Reduced BM cellularity in Nf2/ mice 4 weeks after knockout induction (n = 5, p < 0.01).
(B) Reduced numbers of primitive Lin, Sca1+, c-kit+ cells in BM of Nf2-deficient mice (n = 5, p < 0.05).
(C) Nf2/ mice show enhanced numbers of progenitors in peripheral blood as determined by colony-forming cell (CFC) assays (n = 5, p < 0.01).
(D) Representative FACS plot showing the content of Lin, Sca1+, c-kit+ cells in peripheral blood.
(E) In vivo competitive repopulation assay to measure the content of stem cells in blood through competition with normal BM cells. Results show increased long-
term (16 weeks) repopulating ability of peripheral blood cells from Nf2-deficient mice (n = 4, p = 0.02).
(F) Increased BM cellularity in aged (7 months after polyIC induction) mutant mice (n = 4, p < 0.001).
(G) Increased numbers of primitive hematopoietic cells determined by FACS (Lin, Sca1+, c-kit+) in aged mutant mice (n = 4, p < 0.05).
(H) Competitive repopulating unit (CRU) assays show an increased frequency of HSCs in the BM of aged mutant mice.
Values are mean ± SEM.Nf2 deficiency does not affect stem cell homeostasis through
cell-autonomous mechanisms.
Expansion of Stromal Cells, Elevated VEGF Production,
and Increased Vascular Structures in the Bone Marrow
of Nf2-Deficient Mice
To further elucidate potential mechanisms behind the rapid
egress of hematopoietic stem and progenitor cells from the
bone marrow, we analyzed bone sections from tibias taken 4
weeks after polyIC induction. Histological examination showeda prominent expansion of nonhematopoietic stromal cells distal
to the cartilage zone of the epiphyseal plate in the Nf2 mutants
(Figure 3A). Consistent with this finding, we have also observed
enhanced growth in vitro of Nf2-deficient stroma cells derived
from primary bone marrow cultures (data not shown). The other
prominent finding in the bone sections was a dramatic increase
in the number of vessels in the marrow space of mutant tibias
(Figure 3B). At this stage, bone histomorphometry showed nor-
mal numbers of osteoblasts (Figure S4). Mobilization of HSC/Ps
has been shown to be triggered by high levels of vascular
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prompted us to examine the expression levels of VEGF in the
Nf2 mutant mice, since it could provide a mechanism for both
the increased vessel formation and the mobilization phenotype.
Indeed, expression of VEGF was markedly increased in the mu-
tants, particularly in the areas of stromal cell expansion (Figures
3C and 3D).
We considered two potential mechanisms whereby VEGF
could trigger mobilization. One would be a direct chemokinetic
effect on the HSC/Ps and the other a secondary effect from the
vascular remodeling. We assumed that a chemokinetic effect
would be associated with changes either in the proliferation kinet-
ics or in the expression of adhesion molecules. However, we did
not detect any such changes in hematopoietic cells when assess-
ing the cell cycle status in the primitive LSK cells by BrdU uptake
(Figure S5) or when we measured expression levels of the adhe-
sion molecules CXCR4 and integrin alpha 4, which are known key
mediators of HSC retention in the BM (Figure S6). These findings
suggest that the vascular changes per se are responsible for the
impaired retention of HSC/Ps in the bone marrow.
Figure 2. The HSC Changes Are Non-Cell-
Autonomous and Specifically Dependent
on Alterations in the Bone Marrow Micro-
environment
(A and B) BM chimeras were generated by either
transplantingNf2 floxed BM cells into wild-type re-
cipients or wild-type BM intoNf2 floxed recipients.
Following hematopoietic reconstitution 8 weeks
posttransplantation, the BM chimeras were
treated with polyIC to induce gene deletion in
Nf2 floxed cells. (A) Nf2-deficient progenitors
that have reconstituted a wild-type environment
do not show increased egress into the blood-
stream as measured by CFC assays 4 weeks after
polyIC induction (n = 4, p = NS). (B) Wild-type cells
in an Nf2-deficient environment display a similar
dramatic retention defect as observed in the
Nf2/ mice (n = 4, p < 0.01).
(C and D) Fluorescently labeled wild-type BM cells
were intravenously injected to lethally irradiated
Nf2/ or Nf2 flox/flox control mice. Sixteen hours
later, mice were sacrificed, and the numbers of
homed cells in BM and spleen were determined
by FACS. (C) Reduced homing of c-kit + cells to
the marrow space in Nf2-deficient mice (n = 3, p =
0.01). (D) No alterations in the homing to spleen
could be observed (n = 3, p = NS).
(E and F) Lethally irradiated wild-type mice were
reconstituted with Nf2 floxed BM cells and after
8 weeks treated with polyIC. Seven months later
the BM was analyzed. (E) No alteration in BM cel-
lularity in aged transplant recipients (n = 4, p = NS).
(F) Normal numbers of Nf2-deficient HSCs (Lin,
Sca1+, c-kit+, CD34 cells) in a wild-type environ-
ment (n = 4, p = NS).
Values are mean ± SEM.
Trabecular Bone and Osteoblast
Number Increase in Aged
Nf2-Deficient Mice
We next sought to determine the mecha-
nism behind the elevated HSC numbers
in the aged mutant mice. Osteoblasts have been shown to
have key regulatory functions for HSCs in the endosteal niche
(Calvi et al., 2003; Visnjic et al., 2004; Zhang et al., 2003). Histo-
logical analysis of tibia sections from mice 7 months after polyIC
induction showed a marked increase in trabecular bone in the
mutants (Figure 4A). Both the total bone area and the numbers
of osteoblasts were elevated in the mutant animals (Figures 4B
and 4C). It is possible that these changes have resulted in an ex-
pansion of osteoblastic HSC niches, which in turn could explain
the increased numbers of stem cells in the aged mutant animals.
Several other models have suggested that specific types of alter-
ations that increase osteoblast number can increase HSCs (Calvi
et al., 2003; Zhang et al., 2003).
To further explore the mechanism behind the increased stem
cell numbers, we measured the viability and proliferation kinetics
of HSCs in aged animals (6 months after polyIC treatment) using
cell cycle and apoptosis assays. However, we found no differ-
ence in the cell cycle status or in the frequency of apoptotic
LSK cells in Nf2 mutant mice (Figures 4D and 4E). This
supports our previous conclusion that the phenotype is stem
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pansion is mediated by an overall increased niche capacity
(i.e., a possibility to harbor more stem cells) rather than en-
hanced HSC stimulation from intrinsic or extrinsic factors.
DISCUSSION
We have found that Nf2/merlin plays a crucial role in regulating
several components of the bone marrow microenvironment,
including stromal cells, endothelial cells, and osteoblasts. Our
model suggests that these effects on the microenvironment
have severe consequences for the localization and number of
bone marrow HSCs.
Merlin controls surface availability and signaling from various
membrane receptors in different cell types and model organisms
(Maitra et al., 2006; Curto et al., 2007). In vitro, Nf2-deficient
primary osteoblasts are unable to silence EGFR signaling in
response to intercellular contact, resulting in their continuous
Figure 3. The Nf2-Deficient Mice Display Increased Vascular Struc-
tures and High VEGF Production in the Bone Marrow, which May
Account for the Retention and Homing Defect
Mice were sacrificed 4 weeks after polyIC induction, and the tibial bones were
recovered and processed for histology.
(A) Histology of tibias show a dramatic expansion of nonhematopoietic bone
marrow stromal cells distal to the cartilage zone in the Nf2 mutants (between
arrowheads).
(B) Immunohistochemical staining with the endothelial marker CD31 reveals
a large increase in the number of vessels in the marrow space of mutant tibias.
(C and D) In situ hybridization (C) and immunohistochemistry (D) show mark-
edly increased expression levels of VEGF in tibia sections from the knockout
mice, particularly in areas of stromal cell expansion (between arrowheads).proliferation (Curto et al., 2007). Upon loss of Nf2, similar mech-
anisms might render endothelial cells, osteoblasts, and stromal
cells within the HSC niche unable to silence proliferative signals
from locally acting growth factors such as VEGF, causing the
progressive expansion of the cellular components of niche. We
therefore propose a model where loss of Nf2 leads to a rapid
and substantial expansion of BM stroma cells expressing high
levels of VEGF, which in turn triggers a strong angiogenic
response and, subsequently, mobilization of HSC/Ps. Interest-
ingly, it has been shown that systemic administration of VEGF
triggers efficient HSC/P mobilization in a similar fashion to that
observed in our mice (Hattori et al., 2001). The mobilization effect
could theoretically be mediated by direct VEGF actions on the
hematopoietic cells, but we found no alterations in cell cycle ki-
netics or in expression of adhesion molecules to support this.
The role of VEGF in regulating vasculature is well established.
VEGF induces endothelial cell proliferation and vascular remod-
eling, but it also increases vessel permeability (Connolly et al.,
1989; Senger et al., 1983). The latter effect is visualized by the
presence of leaky vessels in transgenic mice overexpressing
VEGF (Thurston et al., 1999). A likely mechanism for the mobili-
zation phenotype observed in our mice is therefore a VEGF-
mediated induction of more abundant and more permeable
sinusoidal vessels in the bone marrow.
In addition to its role in vitro, merlin has also been implicated in
the regulation of osteoblasts in vivo. Using Cre expressed in neu-
ral crest progenitors and Schwann cells, it was shown that con-
ditional Nf2 mutants develop Schwann cell hyperplasias as well
as schwannomas and osseous metaplasia (Giovannini et al.,
2000). The latter effect was probably due toNf2 deletion in neural
crest-derived osteoblasts (Giovannini et al., 2000). This in com-
bination with the high incidence of osteosarcomas in heterozy-
gous Nf2 mutants, where the second allele has been spontane-
ously deleted, indicates a critical role for merlin in regulation of
osteoblast function (McClatchey et al., 1998). We did not ob-
serve any osteosarcomas during the life span of our animals,
but the bone and osteoblast changes might be viewed as predis-
posing to tumor development. It is tempting to conclude that the
bone phenotype in our model would be a direct consequence of
Nf2 deletion in the osteoblasts. However, due to the late occur-
rence of the bone phenotype, we cannot exclude a secondary ef-
fect where the increased vasculature plays a role as well. Indeed
it has been shown that vascular remodeling induced by angio-
genic factors such as VEGF is associated with increased osteo-
genesis at least during development (Gerber et al., 1999; Suzuki
et al., 2007). It was recently demonstrated that these osteogenic
effects of VEGF are osteoblast nonautonomous and secondary
to the angiogenic response (Wang et al., 2007). To precisely
determine the basis for the bone phenotype, it will be necessary
to generate mice with a cre specific for osteoblasts as well as
endothelial cells.
Our data demonstrate profound and immediate effects on cell
and tissue organization upon loss of merlin function in adult
tissues. This highlights the importance of this gene, not only as
a tumor suppressor, but also as a key regulator of normal tissue
homeostasis, including niche homeostasis. Nf2 deletion exem-
plifies the importance of the niche concept by highlighting the
marked effects of microenvironment on stem cell localization
and function. The relative cellular content, how the cells interact,
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we studied, so we cannot conclude with precision which specific
changes in the architectural organization of the marrow are crit-
ical. However, it is clear that modifying the nonhematopoietic
components of bone marrow profoundly alters hematopoietic
stem cell localization and, ultimately, number.
EXPERIMENTAL PROCEDURES
Mice
Nf2 floxed mice (a gift from Dr. M. Giovannini) were generated as described
previously (Giovannini et al., 2000). The mice were backcrossed at least four
generations on a C57/B6 background and crossed with C57B6 Mx1 Cre trans-
genic mice. Mice were bred in-house in a pathogen-free environment. The
Subcommittee on Research Animal Care of the Massachusetts General Hos-
pital (MGH) approved all animal work according to federal and institutional
policies and regulations. Mice and cell samples were genotyped using
a three-primer strategy to detect wild-type, floxed, and deleted alleles of Nf2
simultaneously as described previously (Giovannini et al., 2000).
Figure 4. Aged Nf2-Deficient Mice Have
Increased Trabecular Bone andOsteoblasts
Mice were sacrificed 6–7 months after polyIC
induction for BM analysis.
(A) Tibial sections from the mutant mice showed
a marked increase in trabecular bone structures
(arrowheads).
(B and C) Bone histomorphometry shows a marked
increase in the relative bone volume (n = 3,
p < 0.05) and in the number of osteoblasts (n = 3,
p < 0.05) in the Nf2 mutant animals.
(D) Cell cycle distribution of Lin, Sca1+, c-kit+
cells measured by Hoechst and Pyronin Y staining.
Representative FACS plots and graph showing
accumulated data (n = 3, p = NS).
(E) Apoptosis assay using Annexin V staining on
Lin, Sca1+, c-kit+ cells. The lower right quadrant
represents early apoptotic cells that are positive
for Annexin V but negative for 7-AAD, which labels
dead cells. Representative FACS plots and graph
showing accumulated data (n = 3, p = NS).
Values are mean ± SEM.
Cell Culture
We performed colony assays by culturing cells in
methylcellulose-containing medium M3434 (Stem
Cell Technologies). To establish cultures of adher-
ent stromal cells, BM cells were passaged in Mye-
locult medium (Stem Cell Technologies).
Flow Cytometry and Cell Sorting
For lineage staining we used a cocktail of biotiny-
lated anti-mouse antibodies to Mac-1a (CD11b),
Gr-1(Ly-6G & 6C), Ter119 (Ly-76), CD33, CD4,
CD8a (Ly-2), and B220 (CD45R) (BD Biosciences).
For detection of HSC-enriched populations, we
used streptavidin conjugated with PE/Cy7, c-Kit-
APC (CD117), Sca1-PE, CD34-FITC (all from BD
Biosciences). For congenic strain discrimination,
anti-CD45.1-PE and anti-CD45.2 FITC antibodies
(BD Biosciences) were used. For BrdU incorpora-
tion we used the FITC-BrdU Flow Kit (BD Biosci-
ences) following administration of an admixture
of 1 mg/ml of BrdU (Sigma) to drinking water for
3 days. For cell cycle analysis, cells were incu-
bated with Hoechst (10 mg/ml) in staining media (HBBS + 10% FCS) and sub-
sequently stained for cell surface markers (same as above except that FITC-
conjugated Sca1 was used). Following fixation overnight (5% PFA) cells
were stained with Pyronin Y and analyzed by flow cytometry. For the apoptosis
assay, we stained cells with lineage markers as above and with Pacific Blue-
conjugated Sca1 and FITC-labeled c-kit. We then used 7-AAD and Annex-
inV-APC according to the manufacturer’s instructions (BD Biosciences) to
label and distinguish dead and early apoptotic cell fractions. For detection of
adhesion molecules, FITC- and PE-conjugated antibodies against CXCR4
and integrin alpha 4, respectively, were used (BD Biosciences).
Transplantation Assays
For all transplantation assays, the B6 congenic CD45.1 and CD45.2 strains
were used to distinguish between test cells, competitor cells, and host cells.
Recipient mice were always lethally irradiated (9.5 Gy), and cells were trans-
planted intravenously through the tail vein. For transplantations to reconstitute
animals prior to polyIC induction, 2 3 106 whole bone marrow cells were
injected. For the competitive repopulation assay with peripheral blood, we
used an equivalent of 200 ml blood competed with 2 3 105 unfractionated
bone marrow cells. For competitive repopulating unit (CRU) assays, we used
226 Cell Stem Cell 3, 221–227, August 7, 2008 ª2008 Elsevier Inc.
Cell Stem Cell
Nf2/Merlin Regulates Stem Cell Behaviorlimiting numbers of test cells 2 3 105, 5 3 104, 1.25 3 104 competed against
2 3 105 support cells. Engraftment efficiency in recipients was monitored by
the relative contribution of CD45.1, CD45.2, or CD45.1 3 CD45.2 cells using
FACS analysis of peripheral blood. For the homing assay, BM cells were la-
beled with 5 mM carboxyfluorescein diacetate succinimidyl ester (CFDA-SE)
(Molecular Probes Inc.) in accordance with the manufacturer’s instructions.
Labeled cells (23 107 per mouse) were injected, and homing to BM and spleen
was measured by the presence of CFDA-SE positive-cells after 16 hr.
Bone Histology and Histomorphometry, In Situ Hybridization,
and Immunohistochemistry
For histological analysis, tissues were fixed and stored as previously described
(Chiusaroli et al., 2003). Hindlimbs were decalcified, and paraffin blocks were
prepared by standard histological procedures. Static histomorphometry was
performed on the same paraffin samples with an Osteomeasure system
(Osteometrics Inc., Atlanta, GA), using standard procedures (Chiusaroli
et al., 2003).
In situ hybridization was carried out as described previously (Chiusaroli
et al., 2003) using complementary 35S-labeled riboprobes on paraffin sections
of bone specimens prepared as above.
For immunohistochemistry, antigen retrieval was carried out with proteinase
K (20 mg/ml, Roche), followed by 3% H2O2 treatment to block endogenous
peroxidase. The TSA Biotin system (PerkinElmer) was used according to the
manufacturer’s instructions. Specimens were incubated with mouse anti-
CD31 antibody (BD biosciences) or anti-VEGF antibody (Santa Cruz Biotech-
nology) for 1 hr at room temperature.
Statistical Analysis
The results are expressed as the mean ± standard error of the mean (SEM) for
n given samples. The Student’s t test or Mann-Whitney’s test was used to
determine the significance of results; significance was set at p values less
than 0.05.
SUPPLEMENTAL DATA
The Supplemental Data include six figures and can be found with this article
online at http://www.cellstemcell.com/cgi/content/full/3/2/221/DC1/.
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